Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Depression as a risk factor for dementia: Link is independent of dementia-related brain changes

  • Popping pills to pushing needles: Prescription opioid abuse among young adults in NYC

  • Preterm children do not have an increased risk for dyscalculia, new research suggests

  • Management of anticoagulant-associated intracerebral hemorrhage

  • Benefits of e-cigarettes outweigh harms, current evidence suggests

  • New mapping approach lets scientists zoom in and out as the brain processes sound

  • Insular cortex alterations in mouse models of autism

  • Political attitudes derive from body and mind: 'Negativity bias' explains difference between liberals and conservatives

  • Study of twins discovers gene mutation linked to short sleep duration

  • First grade reading suffers in segregated schools

  •